600420.SHG Shanghai Shyndec Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
8.36 CNY
Close of Nov 5, 2026
7.67 11.09
Market cap
CNY 11.2B
P/E
24.6x
P/B
0.81x
ROE
3.0%
Dividend yield
3.82%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600420.SHG undervalued?

Graham number
Price8.36
Graham value8.87
Discount5.8%

600420.SHG trades 5.8% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shanghai Shyndec Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Shanghai Shyndec Pharmaceutical Co Ltd yet.

Shanghai Shyndec Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shanghai Shyndec Pharmaceutical Co Ltd

Shanghai Shyndec Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company provides nifedipine controlled release tablets, penicillin industrial potassium salt, touboke yuekui granules/capsules, sodium cefuroxime for injection, D-7ACA, fermented products, milnacipran hydrochloride tablets, compound licorice tablets, and cefoperazone dispersible tablets; and cefuroxime axetil tablets, cefuroxime sod…

Full company profile